Literature DB >> 4586082

A case of active chronic hepatitis with painless erosive arthritis.

D E Barnardo, B Vernon-Roberts, H L Currey.   

Abstract

True arthritis is very much less common than arthralgia in patients suffering from active chronic hepatitis and only scanty information is available about the joint changes in this disease. We report here the case of a young woman with active chronic hepatitis complicated by a painless, erosive small joint arthropathy.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4586082      PMCID: PMC1412784          DOI: 10.1136/gut.14.10.800

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

2.  CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS.

Authors:  M J MACLACHLAN; G P RODNAN; W M COOPER; R H FENNELL
Journal:  Ann Intern Med       Date:  1965-03       Impact factor: 25.391

3.  Lesions of joint and tendon sheaths in systemic lupus erythematosus.

Authors:  B CRUICKSHANK
Journal:  Ann Rheum Dis       Date:  1959-06       Impact factor: 19.103

4.  The problem of chronic liver disease in young women.

Authors:  A G BEARN; H G KUNKEL; R J SLATER
Journal:  Am J Med       Date:  1956-07       Impact factor: 4.965

5.  Articular manifestations of systemic lupus erythematosus.

Authors:  R Labowitz; H R Schumacher
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

6.  Arthritis of hepatitis associated with Australia antigen.

Authors:  D K Onion; C S Crumpacker; B C Gilliland
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

7.  Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival.

Authors:  S P Mistilis; A P Skyring; C R Blackburn
Journal:  Australas Ann Med       Date:  1968-08

8.  The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

Authors:  E Alpert; K J Isselbacher; P H Schur
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

9.  Chronic liver disease in young people. Clinical features and course in thirty-three patients.

Authors:  R G WILLOCX; K J ISSELBACHER
Journal:  Am J Med       Date:  1961-02       Impact factor: 4.965

10.  Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; J M McConville; N C Davis
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  6 in total

1.  Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.

Authors:  K D Rainsford; D R Haynes
Journal:  Inflammopharmacology       Date:  2013-07-04       Impact factor: 4.473

2.  Perspective in liver disease: An Irish experience.

Authors:  M J Whelton
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

3.  Liver disease in patients with joint symptoms.

Authors:  A M Hilton; B E Boyes; P J Smith; J Sharp; I W Dymock
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

Review 4.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

5.  Rheumatic disorders in primary biliary cirrhosis.

Authors:  A K Clarke; R M Galbraith; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

6.  Liver Governs Tendon: A Theory from Traditional Chinese Medicine-Evidence from a Population-Based Matched Cohort Study in Taiwan for the Association of Chronic Liver Disease and Common Diseases in the Chiropractic Office.

Authors:  Chia-Man Ma; Lih-Hwa Lin; Yung-Hsiang Chen; Huey-Yi Chen; Jen-Huai Chiang; Wen-Chi Chen
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-29       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.